It doesn't have enough ratings yet to judge what users think.
VERSPEAK is made and published by PROSTOE RESHENIE. AppBrain is an independent app data site and isn't affiliated with PROSTOE RESHENIE. The app name, icon, screenshots and description belong to PROSTOE RESHENIE and are shown as published on the App Store.
About VERSPEAK
VERSPEAK is a productivity app developed by PROSTOE RESHENIE.
User Ratings
VERSPEAK is rated 5.00 out of 5 stars. The rating is based on one rating ratings.
App Information
VERSPEAK is freely available from the App Store. The app size is 95.12 MB. The latest version available is 1.4.0. The last update was on October 15, 2025.
Technical Requirements
The app has a content rating of Everyone. The app has been available on the App Store since February 2020.
More data about VERSPEAK
| Price | Free |
| Rating | 5.00 based on a single rating |
| Ranking | Not ranked |
| Version | 1.4.0 |
| App size | 95.1 MB |
| Suitable for | Everyone |
Screenshots
Also available on Google Play
Alternatives to VERSPEAK
Changelog of VERSPEAK
No changelog data
Developer information for PROSTOE RESHENIE
Address:
Comments on VERSPEAK for iOS
We don't have enough comments to show example comments. Please check back later.
App Store Rankings for VERSPEAK
Technologies used by VERSPEAK
Frequently asked questions about VERSPEAK
Is VERSPEAK free?
Yes. VERSPEAK is free on the App Store.
Is VERSPEAK still available?
Yes. VERSPEAK is on the App Store, and the last update we saw was on October 15, 2025.
How large is VERSPEAK?
VERSPEAK is 95.12 MB.
Is VERSPEAK suitable for children?
App Store rates the content of VERSPEAK as suitable for everyone.
How do people rate VERSPEAK?
VERSPEAK has one rating of 5.00 stars on the App Store.
Who made VERSPEAK?
VERSPEAK was developed by PROSTOE RESHENIE. It is listed in the productivity category on the App Store.
What are the best alternatives to VERSPEAK?
People looking at VERSPEAK also look at these productivity apps: Sanatorium, ChatBot Turbo AI Assistant, Calendar Reminders Time Notes, ablioaudience, Bfine.